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experience. Nevertheless, as we stated in our
article, Doppler ultrasonography of extracra-
nial arteries should be the basis for choosing
the proper cannulation site in all elective pa-
tients in whom carotid cannulation is
planned. Among almost 250 elective patients
with aortic aneurysm in whom Doppler ul-
trasonography was performed prior to sur-
gery, we saw no significant carotid arterio-
sclerosis of both sides in any patients.
Furthermore, we do not agree with the
letter’s authors that carotid artery cannula-
tion eliminates the circulation through the
vertebral artery during antegrade perfusion.
Cannulation of the right carotid artery pro-
vides the same right vertebral perfusion as
does cannulation of the right axillary artery.
However, as we have demonstrated, it re-
mains questionable whether additional perfu-
sion of the vertebral artery during unilateral
cerebral perfusion under moderate hypother-
mia is even necessary.
Dr AK and Dr Dogan believe that axillary
artery cannulation is superior to carotid artery
cannulation even though they recognized that
several, partly life-threatening, complications
related to axillary cannulation have been
reported. Also, they do not even mention
that axillary cannulation is not always pos-
sible and a switch to other cannulation sites
is necessary in some cases. In our present,
overall experience with almost 300 carotid
artery cannulations, no switch to another
cannulation site was necessary in any pa-
tient, and no vascular, local neurologic, or
wound complications were observed. The
overall stroke rate was 1%. Despite these
results we do not intend to suggest that
carotid cannulation is superior to axillary
cannulation; let the surgical experience
speak for itself.
Paul Urbanski, MD, PhD
Herz- und Gefaess-Klinik
Bad Neustadt, Germany
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Limitations with transapical aortic
cannulation in type A aortic
dissection: What about aortic
regurgitation and cardiopulmonary
bypass time?
To the Editor:
I read with great interest the recent article
by Dr Wada and colleagues1 detailing their
experience with transapical cannulation in
type A dissection (n  138; 22.5% with
significant aortic regurgitation). In their
Methods section, they list the following
contraindications to this technique: severe
aortic stenosis, prior aortic valve replace-
ment, and certain reoperation cases, pre-
sumably with dense adhesions.
What about the impact of significant
aortic regurgitation that occurred com-
monly in this study?2,3 Baseline significant
aortic regurgitation in the setting of
transapical cannulation would be expected
to cause significant retrograde flow into the
left ventricle. The consequences could be
inadequate forward flow with vital organ
ischemia, left ventricular distention with
inadequate myocardial protection, and/or
excessive left ventricular vent return.
The authors conducted this cannulation
technique with echocardiographic guid-
ance. Clearly, the degree of aortic regurgi-
tation and ventricular distention could be
precisely monitored with transesophageal
echocardiography. Careful review of their
article does not reveal their management
strategy for these important considerations.
Last, a possible disadvantage of this
technique is the inability to clamp the as-
cending aorta during cooling, which repre-
sents lost operative time and, as a conse-
quence, extended cardiopulmonary bypass
time with added risk for morbidity. The
authors do not present their cardiopulmo-
nary bypass times in their article.
I would greatly appreciate feedback
from the authors about these intraoperative
considerations.
John G. T. Augoustides, MD, FASE
Department of Anesthesiology
and Critical Care
Hospital of the University of Pennsylvania
Philadelphia, Pa
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Reply to the Editor:
I would like to answer Dr Augoustides’
questions regarding possible aortic regur-
gitation, the disadvantage of not clamping
the aorta, and the prolongation of operative
time with our technique.
In fact, the degree of aortic regurgita-
tion decreased during cardiopulmonary by-
pass with transapical aortic cannulation.
We do not know the exact mechanism, but
this certainly has been our experience.
Type A aortic dissection causes detach-
ment of the commissures of aortic cusps
and prevents central coaptation, resulting
in aortic regurgitation. The aortic flexible
cannula located in the center of the aortic
valve during cardiopulmonary bypass may
enhance coaptation of the leaflets. We
could observe by transesophageal echocar-
diography that the degree of aortic regur-
gitation was decreased.
We consider the inability to clamp the
ascending aorta during cooling not partic-
ularly disadvantageous. Rather, we prefer
the no-clamp technique during cooling on
cardiopulmonary bypass to avoid undue
pressurization or malperfusion of the aortic
false lumen. Our mean cardiopulmonary
bypass time was already presented in our
article; it was 233  68 minutes (median,
222 minutes).
Shinichi Wada, MD
Aortic Center
Kawasaki Saiwai Hospital
Kawasaki-shi, Kanagawa, Japan
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Transapical aortic cannulation: The
technique of choice for type A
dissection
To the Editor:
We congratulate Dr Wada and colleagues
for their excellent and extensive experience
in transapical aortic cannulation for type A
dissection.1 Although first described more
than 35 years ago,2 transapical aortic can-
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nulation remains widely accepted and pop-
ularized for reasons that remain unclear.
This is despite the fact that it is the most
“physiologic” approach in establishing car-
diopulmonary bypass in acute type A aortic
dissection. We have been using this tech-
nique exclusively since 1995 for the rea-
sons outlined by Dr Wada and associates.
However, we would like to share additional
valuable comments that our experience has
demonstrated.
Although placement of the aortic cannula
through the aortic valve into the true lumen is
desirable, it is not essential. In some cases of
cardiomegaly we found that the cannula was
too short to traverse the aortic valve. The tip
was therefore guided into the left ventricular
outflow tract under transesophageal echocar-
diography. We encountered no compromise
in perfusion pressures, flow rates, or ventric-
ular distension. Furthermore, although Dr
Wada and colleagues suggest that the tech-
nique is not practical after previous cardiac
surgery, our experience is to the contrary. We
recently used the transapical approach in a
patient who presented with recurrent type A
aortic dissection some years after his initial
presentation. The dissection flap involved
both femoral arteries and neck vessels, pre-
cluding all other sites for extrathoracic can-
nulation. The left ventricular apex was easily
exposed through a small left thoracotomy
and a 21F Bio-Medicus cannula (Medtronic,
Minneapolis, Minn) introduced through a
stab incision. The presence of such patients
with no option for extrathoracic cannulation
because of extensive dissection is not un-
common, and they would otherwise be
denied surgery. However, perfusion of
the true lumen can be ensured with the
transapical approach.
The theoretic disadvantages to the ap-
proach include potential problems with the
stab incision repair. Our arterial cannula is
designed for percutaneous femoral cannu-
lation and has a rigid sharp introducer. Our
stab incision, which measures less than
4 mm, is not full thickness because the myo-
cardium is split along the fibers by the
cannula rather than cut by a knife. In our
experience the size of the wound is similar
to that when an apical vent is used for
conventional aortic valve replacement. Be-
cause of the small wound size, we do not
routinely use pledgets for repair but place a
horizontal mattress 4-0 polypropylene su-
ture with an over-and-over running suture.
To date we have encountered no technical
difficulty with the repair site.
In conclusion, our experience supports
the use of transapical cannulation as the
method of choice for arterial inflow in type A
dissection. We strongly advocate its routine
use and are grateful to Dr Wada and col-
leagues for confirming it in their large series.
Rajwinder S. Jutley, MD, MRCS
Nicola Masala, MD
A. W. Sosnowski, MD, FRCS
Department of Cardiac Surgery
Glenfield Hospital
Leicester, United Kingdom
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Reply to the Editor:
We appreciate the comments of Dr Jutley
and colleagues concerning our recent arti-
cle.1 As they said, transapical aortic can-
nulation is the most physiologic approach
to establish cardiopulmonary bypass in
type A aortic dissection.
We would like to give some additional
explanation related to their comments. Our
cannula is long enough to traverse the aor-
tic valve in patients with cardiomegaly
(Figure 1, A). It is necessary that our stab
incision, which measures approximately
1 cm, be full-thickness myocardium be-
cause the tip of this cannula is not sharp
(Figure 1, B). As a result, we routinely
close the incision with a few (usually 3) 4-0
polyvinylidene fluoride interrupted sutures
with felt pledgets. There were no bleeding
problems after performing stab-wound can-
nulation and closing the incision with this
technique.
Shinichi Wada, MD
Shin Yamamoto, MD, PhD
Yasuyuki Hosoda, MD
Aortic Center
Kawasaki Saiwai Hospital
Kanagawa, Japan
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Off-pump coronary artery bypass
sacrifices graft patency
To the Editor:
We are grateful to Dr Gardner1 for his
editorial regarding our meta-analysis2 of
randomized controlled trials of off-pump
coronary artery bypass (OPCAB) versus
conventional coronary artery bypass graft-
ing (CABG), and we absolutely agree with
his statement: “the choice of which tech-
nique (of OPCAB or CABG) to use should
remain the surgeon’s option.” However,
we, in the era of evidence-based medicine,
are convinced that the surgeon’s option
should be based on the best evidence, such
as a meta-analysis of randomized con-
trolled trials (type Ia evidence recom-
mended by the Agency for Health Care
Policy and Research).
The meta-analysis of 37 randomized tri-
als (3369 patients) of OPCAB versus
CABG by Cheng and associates,3 pub-
lished in 2005, demonstrated that no sig-
nificant differences were found for 30-day
mortality, myocardial infarction, stroke, re-
nal dysfunction, intraaortic balloon pump,
wound infection, rethoracotomy, or reinter-
vention. However, OPCAB significantly
decreased arterial fibrillation, transfusion,
inotrope requirements, respiratory infec-
tions, ventilation time, intensive care unit
stay, and hospital stay.3 Therefore, OPCAB
Figure 1. Sarns Soft-flow Extended Aortic
Cannula (Terumo Cardiovascular Systems,
Corp, Ann Arbor, Mich).
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